DHR
Danaher Corporation
$171.16
-2.56%
2026-05-08
About Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.
Key Fundamentals
P/E Ratio
33.65
Forward P/E
19.09
EPS (TTM)
$5.16
ROE
7.1%
Revenue Growth (YoY)
3.7%
Profit Margin
14.9%
Debt/Equity
37.17
Dividend Yield
0.9%
Price/Book
2.32
Beta
0.84
Market Cap
$122.88B
Avg Volume (10D)
5.1M
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$219.60
60D Low
$170.75
Avg Volume
4.1M
Latest Close
$171.16
Get breakout alerts for DHR
Sign up for Breakout Scanner to receive daily notifications when DHR triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Danaher Corporation (DHR) is listed on the New York Stock Exchange (NYSE). Breakout Scanner monitors DHR daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. DHR operates in the Healthcare sector within the Diagnostics & Research industry. Data is provided for informational purposes only and does not constitute financial advice.